![]() |
|
|
|
You are here: Clinical Trials >
Information obtained from ClinicalTrials.gov on June 16, 2008 Link to the current ClinicalTrials.gov record. Condition(s) treated: Acne Scarring Intervention: Subdermal Manipulation (Procedure); Calcium Hydroxylapatite (Drug) Phase: Phase 4 Enrollment status: Recruiting Sponsor: Northwestern University
Principal investigator(s) or official(s):
Overall contact:
The primary objective of this study is to look at the efficacy of subdermal manipulation in the improvement of acne scar appearance. We hypothesize that subdermal manipulation with an injectable filler would be efficacious in improving scar appearance due to new collagen formation.
Official title: Treatment of Acne Scarring With Subdermal Manipulation Study design: Treatment, Randomized, Single Blind, Active Control, Single Group Assignment, Efficacy Study Primary outcome: Scar Improvement (Time Frame: 3.5 months) Secondary outcome: Adverse Events (Time Frame: 3.5 months) Detailed description: The primary objective of this study is to look at the efficacy of subdermal manipulation in the improvement of acne scar appearance. We hypothesize that subdermal manipulation with an injectable filler will be efficacious in improving scar appearance due to new collagen formation.
Minimum eligible age: 18 Years. Eligible gender(s): Both. Criteria: Inclusion Criteria:
Nicolle Martin, MD, Phone: 312-695-0281, Email: nicolle-martin@northwestern.edu Northwestern University, Feinberg School of Medicine, Department of Dermatology, Chicago, Illinois 60611, United States; Recruiting
Start date: June 2007
Home | About Us | Contact Us | Ask a Question | Resources Copyright © 1999-2008 by Dr. G. Todorov / SmartSkinCare.com Site Disclaimer | Copyright Certification
|
|